Compare UAA & LMAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | UAA | LMAT |
|---|---|---|
| Founded | 1996 | 1983 |
| Country | United States | United States |
| Employees | N/A | 655 |
| Industry | Apparel | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.9B | 1.8B |
| IPO Year | 2005 | 2006 |
| Metric | UAA | LMAT |
|---|---|---|
| Price | $4.67 | $80.14 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 27 | 8 |
| Target Price | $6.27 | ★ $107.00 |
| AVG Volume (30 Days) | ★ 8.0M | 188.3K |
| Earning Date | 11-05-2026 | 11-05-2026 |
| Dividend Yield | N/A | ★ 1.21% |
| EPS Growth | N/A | ★ 30.57 |
| EPS | N/A | ★ 1.42 |
| Revenue | ★ $4,966,370,000.00 | $249,602,000.00 |
| Revenue This Year | N/A | $10.79 |
| Revenue Next Year | $2.51 | $9.54 |
| P/E Ratio | ★ N/A | $58.69 |
| Revenue Growth | N/A | ★ 13.53 |
| 52 Week Low | $4.13 | $78.22 |
| 52 Week High | $8.15 | $118.01 |
| Indicator | UAA | LMAT |
|---|---|---|
| Relative Strength Index (RSI) | 32.64 | 54.99 |
| Support Level | N/A | $82.58 |
| Resistance Level | $5.39 | $84.35 |
| Average True Range (ATR) | 0.18 | 1.57 |
| MACD | -0.01 | 0.71 |
| Stochastic Oscillator | 24.60 | 94.31 |
Under Armour develops, markets, and distributes athletic apparel, footwear, and accessories in North America, Asia-Pacific, Europe, and Latin America. Consumers of its performance-based clothing and shoes include professional and amateur athletes, sponsored college and professional teams, and people with active lifestyles. The company sells merchandise through wholesale partners, company-owned digital channels, and approximately 440 company-owned outlet and full-price stores. The Baltimore-based firm was founded in 1996 and is led by controlling shareholder Kevin Plank.
LeMaitre Vascular Inc is a provider of medical devices and human tissue cryopreservation services mainly used in the treatment of peripheral vascular disease, end-stage renal disease, and cardiovascular disease. The company develops, manufactures, and markets vascular devices to address the needs of vascular surgeons and, to a lesser extent, other specialties such as cardiac surgeons, general surgeons, and neurosurgeons. Its diversified portfolio consists of branded products used in arteries and veins that are well known to vascular surgeons. It operates across the Americas, Europe, the Middle East and Africa, and Asia Pacific, with the majority of its revenue generated from the Americas.